Showing results (71-80 of 184) with videos related to
Sort By:
Pageof 19
Cardioscience|December 1, 1993
Global myocardial ischemia protects the myocardium from subsequent regional ischemiaD M Walker, J M Walker, D M YellonJournal of Molecular and Cellular Cardiology|August 1, 1995
Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cellsR J Heads, D M Yellon, D S LatchmanCardiovascular Research|January 1, 1996
Pre-conditioning with adenosine leads to concentration-dependent infarct size reduction in the isolated rabbit heartR G Woolfson, V C Patel, D M YellonCardiovascular Drugs and Therapy|December 1, 1995
Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practiceD P Jenkins, S E Steare, D M YellonCardioscience|September 1, 1993
The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protectionA M Alkhulaifi, W B Pugsley, D M YellonJournal of Cardiovascular Pharmacology|July 1, 1989
Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarctsJ G Kingma, A R Denniss, D M YellonEuropean Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1994
Preconditioning the human heart during aorto-coronary bypass surgeryA M Alkhulaifi, D M Yellon, W B PugsleyEuropean Heart Journal|November 1, 1986
Can beta blockers limit myocardial infarct size?D J Hearse, D M Yellon, J M DowneyBasic Research in Cardiology|July 13, 2005
Adrenomedullin limits reperfusion injury in experimental myocardial infarctionS A Hamid, G F BaxterBritish Journal of Pharmacology|October 24, 2007
Reperfusion and calculated RISKs: pharmacological postconditioning of human myocardiumG F Baxter, D S BurleyPageof 19